在蒙古国注册的冰鲜、冷冻猪肉企业名单(共11家) the List of the Designated Chilled and Frozen Pork Establishments in Mongolia(Total 11)
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Table of Codes for Each Court of Each Level
Table of Codes for Each Court of Each Level Corresponding Type Chinese Court Region Court Name Administrative Name Code Code Area Supreme People’s Court 最高人民法院 最高法 Higher People's Court of 北京市高级人民 Beijing 京 110000 1 Beijing Municipality 法院 Municipality No. 1 Intermediate People's 北京市第一中级 京 01 2 Court of Beijing Municipality 人民法院 Shijingshan Shijingshan District People’s 北京市石景山区 京 0107 110107 District of Beijing 1 Court of Beijing Municipality 人民法院 Municipality Haidian District of Haidian District People’s 北京市海淀区人 京 0108 110108 Beijing 1 Court of Beijing Municipality 民法院 Municipality Mentougou Mentougou District People’s 北京市门头沟区 京 0109 110109 District of Beijing 1 Court of Beijing Municipality 人民法院 Municipality Changping Changping District People’s 北京市昌平区人 京 0114 110114 District of Beijing 1 Court of Beijing Municipality 民法院 Municipality Yanqing County People’s 延庆县人民法院 京 0229 110229 Yanqing County 1 Court No. 2 Intermediate People's 北京市第二中级 京 02 2 Court of Beijing Municipality 人民法院 Dongcheng Dongcheng District People’s 北京市东城区人 京 0101 110101 District of Beijing 1 Court of Beijing Municipality 民法院 Municipality Xicheng District Xicheng District People’s 北京市西城区人 京 0102 110102 of Beijing 1 Court of Beijing Municipality 民法院 Municipality Fengtai District of Fengtai District People’s 北京市丰台区人 京 0106 110106 Beijing 1 Court of Beijing Municipality 民法院 Municipality 1 Fangshan District Fangshan District People’s 北京市房山区人 京 0111 110111 of Beijing 1 Court of Beijing Municipality 民法院 Municipality Daxing District of Daxing District People’s 北京市大兴区人 京 0115 -
Annual Report 2020 3 Message to Shareholders
Contents Financial Highlights 2 Corporate Information 3 Message to Shareholders 4 Management Discussion and Analysis 7 Biographical Details of Directors and Senior Management 20 Corporate Governance Report 23 Report of the Directors 45 Independent Auditor’s Report 61 Consolidated Financial Statements Consolidated Statement of Profit or Loss and Other Comprehensive Income 64 Consolidated Statement of Financial Position 65 Consolidated Statement of Changes in Equity 67 Consolidated Statement of Cash Flows 70 Notes to the Consolidated Financial Statements 72 Five Year Financial Summary 154 Financial Highlights FINANCIAL HIGHLIGHTS 2020 2019 Change % Revenue (HK$’Mn) 849 4,561 (81.4) Gross profit (HK$’Mn) 74 204 (63.7) Loss for the year (HK$’Mn) (2,433) (1,116) N/A Loss attributable to owners of the Company (HK$’Mn) (2,430) (1,068) N/A Basic loss per share (HK cents) (28.6) (15.5) N/A Proposed final dividend per share (HK cents) — — N/A HK$ million 6000 2020 2019 5000 4,561 4000 3000 2000 1000 849 74 204 0 -1000 (1,116) -2000 (2,433) -3000 Revenue Gross profit Loss for the year 2 Global Bio-chem Technology Group Company Limited Corporate Information BOARD OF DIRECTORS PRINCIPAL BANKERS Executive Directors Bank of China (Hong Kong) Limited Mr. Yuan Weisen (Resigned on 9 February 2021) Bank of China Tower Mr. Zhang Zihua (Acting Chairman) 1 Garden Road Mr. Liu Shuhang Hong Kong Non-executive Directors The Agriculture Bank of China Mr. Gao Dongsheng (Appointed on 30 June 2020) 6 Beian Road Ms. Liang Wanpeng (Resigned on 30 June 2020) Nanguan District Changchun, Jilin Province Independent non-executive Directors The People’s Republic of China Ms. -
Global Sweeteners 2020 Net Loss Significantly
PRESS RELEASE To: Business Editors GLOBAL SWEETENERS 2020 NET LOSS SIGNIFICANTLY NARROWED TO HK$8.7 MILLION REMOVAL OF DISCLAIMER OPINION IN RELATION TO THE FINANCIAL GUARANTEES IN THE FINANCIAL STATEMENTS FOR THE YEAR ENDING 31 DECEMBER 2021 31 March 2021 – Global Sweeteners Holdings Limited (“Global Sweeteners” or the “Company”, stock code: 03889) together with its subsidiaries (the “Group”) reported a 60.7 per cent year-on-year decrease in its consolidated revenue for the year ended 31 December 2020 (the “Year”) to HK$769 million; gross profit also declined by approximately 62.5 per cent year-on-year to HK$77.9 million. Such decreases were mainly attributable to the significant drop in sales volume. During the year, due to the continued impact of the COVID-19 pandemic, the slowdown in economic growth and tight operating cash flow of the Group amid the prolonged challenging operating environment, the Group consolidated its resources in the Shanghai production site, which had higher operational efficiency while suspending the operation of the other low efficiency production facilities. As a result, the Group’s gross profit margin decreased only slightly by approximately 0.5 percentage point to approximately 10.1 per cent during the Year. Due to the recognition of a one-off gain from the resumption of the properties owned by Changchun Dihao Foodstuff Development Co., Ltd. (“Dihao Foodstuff”), the Group recorded earnings before interest, taxation, depreciation and amortisation (EBITDA) of HK$201.4 million (2019: LBITDA of HK$22.9 million) , with net loss significantly narrowed to approximately HK$8.7 million (2019: HK$162.6 million). -
Jilin Province Chuncheng Heating Company Limited* 吉林省春城熱力股份有限公司
Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this announcement. Jilin Province Chuncheng Heating Company Limited* 吉林省春城熱力股份有限公司 (A joint stock limited liability company incorporated in the People’s Republic of China) (Stock code: 1853) ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED 31 DECEMBER 2020 FINANCIAL HIGHLIGHTS FOR THE 2020 RESULTS ANNOUNCEMENT • The revenue for the year ended 31 December 2020 was RMB1,897 million, representing an increase of 21.49% over the comparative figure of 2019 • The profit before tax for the year ended 31 December 2020 was RMB204 million, representing an increase of 13.38% over the comparative figure of 2019 • The net profit attributable to equity holders of the Company for the year ended 31 December 2020 was RMB165 million, representing an increase of 23.32% over the comparative figure of 2019 • Earnings per share for the year ended 31 December 2020 was RMB0.35, unchanged from the comparative figure of 2019 • The Board proposed the distribution of a final dividend of RMB0.103 per share (tax inclusive) for the year ended 31 December 2020. The board of Directors (the “Board”) is pleased to announce the consolidated results of the Company and its subsidiaries (collectively, the “Group”) for the year ended 31 December 2020, together with the comparative figures for the year ended 31 December 2019. -
Press Release
Press Release To: Business Editors GLOBAL BIO-CHEM’S 2019 REVENUE REACHED HK$4,561 MILLION, WITH A GROSS PROFIT OF HK$204 MILLION 26 March 2020 – Affected by the African Swine Fever (“ASF”), Global Bio-chem Technology Group Company Limited (“Global Bio-chem” or “the Company”, stock code: 00809) together with its subsidiaries (the “Group”) reported a 19.4 per cent year-on-year decrease in revenue for the year ended 31 December 2019 (the “Year”) to HK$4,561.4 million and a 21.6 per cent drop in gross profit to approximately HK$203.5 million. Due to the recognition of a one-off compensation for the resumption of the disposal of land and buildings located in Luyuan District, Changchun during the Year, the net loss of Group was narrowed to HK$1,116.3 million (2018: HK$1,299.2 million), and recorded EBITDA (i.e. earning before interest, taxation, depreciation and amortisation)of HK$32.4 million (2018: LBITDA(i.e. loss before interest, taxation, depreciation and amortisation): HK$299.1 million). The board of directors of Global Bio-chem does not recommend the payment of a final dividend for the Year (2018: nil). During the Year, the Group’s downstream amino acids segment was hit under the influence of the ASF, while the sweeteners segment was challenged by intensified market competition. In particular, demand for lysine products in both the domestic market and the overseas market had shrunk significantly during the Year. In view of this, the Group has suspended the amino acids production since August 2019 to minimise cash outflow. -
中國內地指定醫院列表 出版日期: 2019 年 7 月 1 日 Designated Hospital List in Mainland China Published Date: 1 Jul 2019
中國內地指定醫院列表 出版日期: 2019 年 7 月 1 日 Designated Hospital List in Mainland China Published Date: 1 Jul 2019 省 / 自治區 / 直轄市 醫院 地址 電話號碼 Provinces / 城市/City Autonomous Hospital Address Tel. No. Regions / Municipalities 中國人民解放軍第二炮兵總醫院 (第 262 醫院) 北京 北京 西城區新街口外大街 16 號 The Second Artillery General Hospital of Chinese 10-66343055 Beijing Beijing 16 Xinjiekou Outer Street, Xicheng District People’s Liberation Army 中國人民解放軍總醫院 (第 301 醫院) 北京 北京 海澱區復興路 28 號 The General Hospital of Chinese People's Liberation 10-82266699 Beijing Beijing 28 Fuxing Road, Haidian District Army 北京 北京 中國人民解放軍第 302 醫院 豐台區西四環中路 100 號 10-66933129 Beijing Beijing 302 Military Hospital of China 100 West No.4 Ring Road Middle, Fengtai District 中國人民解放軍總醫院第一附屬醫院 (中國人民解 北京 北京 海定區阜成路 51 號 放軍 304 醫院) 10-66867304 Beijing Beijing 51 Fucheng Road, Haidian District PLA No.304 Hospital 北京 北京 中國人民解放軍第 305 醫院 西城區文津街甲 13 號 10-66004120 Beijing Beijing PLA No.305 Hospital 13 Wenjin Street, Xicheng District 北京 北京 中國人民解放軍第 306 醫院 朝陽區安翔北里 9 號 10-66356729 Beijing Beijing The 306th Hospital of PLA 9 Anxiang North Road, Chaoyang District 中國人民解放軍第 307 醫院 北京 北京 豐台區東大街 8 號 The 307th Hospital of Chinese People’s Liberation 10-66947114 Beijing Beijing 8 East Street, Fengtai District Army 中國人民解放軍第 309 醫院 北京 北京 海澱區黑山扈路甲 17 號 The 309th Hospital of Chinese People’s Liberation 10-66775961 Beijing Beijing 17 Heishanhu Road, Haidian District Army 中國人民解放軍第 466 醫院 (空軍航空醫學研究所 北京 北京 海澱區北窪路北口 附屬醫院) 10-81988888 Beijing Beijing Beiwa Road North, Haidian District PLA No.466 Hospital 北京 北京 中國人民解放軍海軍總醫院 (海軍總醫院) 海澱區阜成路 6 號 10-66958114 Beijing Beijing PLA Naval General Hospital 6 Fucheng Road, Haidian District 北京 北京 中國人民解放軍空軍總醫院 (空軍總醫院) 海澱區阜成路 30 號 10-68410099 Beijing Beijing Air Force General Hospital, PLA 30 Fucheng Road, Haidian District 中華人民共和國北京市昌平區生命園路 1 號 北京 北京 北京大學國際醫院 Yard No.1, Life Science Park, Changping District, Beijing, 10-69006666 Beijing Beijing Peking University International Hospital China, 東城區南門倉 5 號(西院) 5 Nanmencang, Dongcheng District (West Campus) 北京 北京 北京軍區總醫院 10-66721629 Beijing Beijing PLA. -
出版日期: 2018 年1 月- Designated Hospital List in Mainland China
中國內地指定醫院列表 (((生活守護保障(生活守護保障))) 出版日期: 2018 年年年 1 月月月 Designated Hospital List in Mainland China (Life Impact Reliever) Published Date: Jan 2018 省省省 / 自治區 / 直直直 轄市 Provinces / 城市 醫院 地址 電話號碼 Autonomous City Hospital Address Tel. No. Regions / Municipalities 安徽省 合肥 合肥市第一人民醫院 盧陽區淮河路 390 號 551-2652893 Anhui Hefei Hefei No.1 People's Hospital 390 Huaihe Road, Luyang District 安徽省 合肥 合肥市第二人民醫院 包河區和平路 246 號 551-2203500 Anhui Hefei Hefei No.2 People's Hospital 246 Heping Road, Yaohai District 安徽省 合肥 安徽中醫學院第一附屬醫院 (安徽省中醫院) 蜀山區梅山路 117 號 551-2821852 Anhui Hefei Anhui TCM College No. 1 Hospital 117 Meishan Road, Shushan District 安徽省 合肥 安徽省立兒童醫院 包河區望江東路 39 號 551-2237114 Anhui Hefei Anhui Children's Hospital 39 Wangjiang East Road, Baohe District 安徽省 合肥 安徽省立醫院 廬陽區廬江路 17 號 551-2283114 Anhui Hefei Anhui Hospital 17 Lujiang Road, Luyang District 安徽省 合肥 安徽醫科大學第一附屬醫院 蜀山區績溪路 218 號 551-2922114 Anhui Hefei Anhui Medical University No.1 Hospital 218 Jixi Road, Shushan District 安徽省 合肥 安徽醫科大學第二附屬醫院 經濟技術開發區芙蓉路 678 號 551-3869420 Anhui Hefei Anhui Medical University No.2 Hospital 678 Furong Road, Shushan District 中國中醫科學院廣安門醫院 北京 北京 西城區北線閣 5 號 Guang'anmen Hospital, China Academy of Chinese 10-83123311 Beijing Beijing 5 Beixiange St. Xicheng District Medical Sciences 北京 北京 中國中醫科學院望京醫院 朝陽區花家地街 10-84739047 Beijing Beijing Wangjing Hospital of CACMS Huajiadi Street, Chaoyang District 北京 北京 中國中醫科學院西苑醫院 (西苑醫院) 海澱區西苑操場 1 號 10-62835678 Beijing Beijing Xiyuan Hospital CACMS No.1, Xiyuang Caochang, Haidian District 北京 北京 中國人民解放軍海軍總醫院 (海軍總醫院) 海澱區阜成路 6 號 10-66958114 Beijing Beijing PLA Naval General Hospital 6 Fucheng Road, Haidian District 北京 北京 中國人民解放軍空軍總醫院 (空軍總醫院) 海澱區阜成路 30 號 10-68410099 Beijing Beijing Air Force General Hospital, PLA 30 Fucheng Road, Haidian District 北京 北京 中國人民解放軍第 302 醫院 豐台區西四環中路 100 號 10-66933129 Beijing Beijing 302 Military Hospital of China 100 West No.4 Ring Road Middle, Fengtai District 重要資料: Important Notes: 1. -
Second Circular (.Pdf)
THE SECOND CIRCULAR INTERNATIONAL WORKSHOP ON MULTI-WELL DEEP UNDERGROUND LABORATORY IN EASTERN CHINA July 3-8, 2016 CHANGCHUN, CHINA WORKSHOP VENUE Since the announcement of “International Workshop on Multi-Well Deep Underground Laboratory in Eastern China”, we’ve received active responses from both international and domestic colleagues. The workshop will be held in the Changchun Huatian Hotel (Fig.1, See below), Changchun, Jilin Province of China, from July 3-8, 2016. The contact information of the meeting place is: Address: Changchun Huatian Hotel, No.2288, Jingyang Road of Luyuan District, Changchun, China ; Tel: +86-431-87809999; Fax: +86-431-87809688; Email: [email protected]. Early July is summer in Changchun, and the climate is quite warm. The temperature during that time is approximately around 20-28 0C on average. Fig.1 The locality of Huatian Hotel AIM OF THE WORKSHOP A deep underground laboratory (DUL) is defined here as a facility and experimental platform designed for long-term, continuous, real-time, and in-situ detection and observation of various underground physical, chemical and biological processes that are important to sustainable development of natural resources, while maintaining a clean environment. We hope to build a deep underground laboratory, which will primarily be developed from existing wells in the Songliao Basin and nearby underground space. Some currently operating earthquake and volcano monitoring stations along the Tan-Lu fault zone could also be part of the laboratory. The first set of scientific objectives of this laboratory includes: 1) Detection and exploration of fluid and the deep biosphere; 2) Geological CO2 emission and deep carbon cycle; 3) Earthquake and volcanic activity monitoring; 4) Development of enhanced geothermal system (EGS). -
Directors and Parties Involved in the Share Offer
DIRECTORS AND PARTIES INVOLVED IN THE SHARE OFFER DIRECTORS Name Address Nationality Executive Directors KONG Zhanpeng ( ) Flat E, 22nd Floor, Block 5 Chinese (Chairman) The Waterfront 1AustinRoad Tsimshatsui Kowloon Hong Kong ZHANG Fusheng ( ) No. 601, Block 11, Wanke City Garden Chinese No. 4369 Ziyou Road Erdao District Changchun Jilin Province The PRC WANG Guifeng ( ) Room 302, Block 8, Zhongxin Garden Chinese No. 178 Xian Road Luyuan District Changchun Jilin Province The PRC GE Yanping ( ) Rom 102, Block 3 Chinese 399 Shiping Road Minhang District Shanghai The PRC Independent non-executive Directors FUNG Siu Wan Stella Flat A, 35th Floor Canadian ( ) Winsome Park 42 Conduit Road Hong Kong YAN Man Sing Frankie Room 604, Block 29 British ( ) Heng Fa Chuen Chai Wan Hong Kong HO Lic Ki ( ) Flat C, 27th Floor, Tower 2 Chinese Robinson Heights 8 Robinson Road Hong Kong GAO Yunchun ( ) No. 26 Xinhua Road Chinese Chaoyang District Changchun Jilin Province The PRC —57— DIRECTORS AND PARTIES INVOLVED IN THE SHARE OFFER PARTIES INVOLVED Sponsor Goldbond Capital (Asia) Limited 3902B, 39th Floor, Tower 1 Lippo Centre 89 Queensway Hong Kong Sole Bookrunner and Goldbond Securities Limited Sole Global Coordinator 3901B, 39th Floor, Tower 1 Lippo Centre 89 Queensway Hong Kong Joint Lead Managers Goldbond Securities Limited 3901B, 39th Floor, Tower 1 Lippo Centre 89 Queensway Hong Kong DBS Asia Capital Limited 22nd Floor, The Center 99 Queen’s Road Central Hong Kong Public Offer Underwriters Goldbond Securities Limited 3901B, 39th Floor, Tower 1 Lippo -
(PM10 and PM2.5) in Changchun and Analysis of Its Influencing Factors
atmosphere Article Temporal and Spatial Distribution Characteristics of Atmospheric Particulate Matter (PM10 and PM2.5) in Changchun and Analysis of Its Influencing Factors Ju Wang, Xin Xie and Chunsheng Fang * College of New Energy and Environment, Jilin University, Changchun 130012, China; [email protected] (J.W.); [email protected] (X.X.) * Correspondence: [email protected]; Tel.: +86-431-8850-2607 Received: 27 September 2019; Accepted: 24 October 2019; Published: 28 October 2019 Abstract: With Changchun’s economic development, atmospheric particulate pollution has become a significant challenge in Changchun. The spatiotemporal patterns of particulate matter emissions are an inherent characteristic for particulate matter emissions. By using hourly PM (particulate matter) mass concentration measured at 10 atmospheric automatic monitoring stations and meteorological parameters, the spatiotemporal distribution characteristics of particulate matter (PM10 and PM2.5) and its relationship with meteorological parameters of Changchun have been analyzed. Pollution pathways and source distribution were investigated using HYSPLIT (Hybrid Single Particle Lagrangian Integrated Trajectory) model and cluster analysis. Results indicated that the quarterly average PM2.5 and PM10 mass concentrations in Changchun were higher in the first quarter and the fourth quarter. PM concentrations observed in all seasons generally exhibited two peaks, at 07:00–10:00 and 21:00–23:00, with the exception of PM10 in spring. PM pollution was concentrated mainly in the central, northern, and western areas of Changchun in most seasons, mainly due to anthropogenic activities and soil dust transported outside the region. PM concentrations were negatively correlated with relative humidity and temperature. PM2.5 concentrations were negatively correlated with wind speed, while PM10 concentrations were positively correlated with wind speed. -
Interim Report 2020 中期報告 中期報告 Contents
Interim Report 2020 中期報告 告 中期報 Contents Financial Highlights 2 Corporate Information 3 Message to Shareholders 4 Management Discussion and Analysis 7 Disclosure of Additional Information 19 Condensed Consolidated Financial Statements Condensed Consolidated Statement of Profit or Loss and 29 Other Comprehensive Income Condensed Consolidated Statement of Financial Position 30 Condensed Consolidated Statement of Changes in Equity 32 Condensed Consolidated Statement of Cash Flows 33 Notes to Condensed Consolidated Financial Statements 35 Financial Highlights Six months ended 30 June 2020 2019 Change % (Unaudited) (Unaudited) Revenue (HK$’Mn) 479.1 2,799.4 (82.9) Gross profit (HK$’Mn) 40.9 53.8 (24.0) Loss before tax (HK$’Mn) (902.8) (838.2) N/A Loss for the period (HK$’Mn) (902.8) (838.2) N/A Basic loss per share (HK cents) (10.5) (12.5) N/A Interim dividend per share (HK cents) Nil Nil N/A HK$ million 3000 1H 2020 2,799.4 1H 2019 2000 1000 479.1 40.9 53.8 0 -1000 (902.8) (838.2) Revenue Gross profit Loss for the period 2 Global Bio-chem Technology Group Company Limited Corporate Information BOARD OF DIRECTORS PRINCIPAL BANKERS Executive Directors Bank of China (Hong Kong) Limited Mr. Yuan Weisen (Chairman) 1 Garden Road Mr. Zhang Zihua Hong Kong Mr. Liu Shuhang The Agriculture Bank of China Non-executive Directors 6 Beian Road Mr. Gao Dongsheng (Appointed on 30 June 2020) Nanguan District Ms. Liang Wanpeng (Resigned on 30 June 2020) Changchun, Jilin Province The People’s Republic of China Independent non-executive Directors Ms. -
Environmental, Social and Governance Report Contents
Environmental, Social and Governance Report Contents ABOUT THIS REPORT 2 MESSAGE FROM CHAIRMAN 5 1. WORKPLACE QUALITY 6 1.1 WORKPLACE CONDITIONS 6 1.2 OCCUPATIONAL HEALTH AND SAFETY 10 1.3 OCCUPATIONAL DEVELOPMENT AND TRAINING 12 1.4 LABOUR STANDARDS 16 2. ENVIRONMENTAL PROTECTION 17 2.1 EMISSION 18 2.2 USE OF RESOURCES 22 2.3 EFFECTS ON THE ENVIRONMENT AND NATURAL 29 HABITATS 3. OPERATING PRACTICES 31 3.1 SUPPLY CHAIN MANAGEMENT 31 3.2 PRODUCT SAFETY 37 3.3 ANTI-CORRUPTION 45 4. COMMUNITY INVOLVEMENT 46 ABOUT THIS REPORT Introduction Global Bio-chem Technology Group Company Limited (“GBT” or the “Company”) and its subsidiaries (collectively referred to as the “Group”) are principally engaged in the manufacture and sale of corn refined products, amino acids, corn sweeteners and polyol chemicals. We are aware that sustainable economic development and improvement of the livelihood of the population are the key trends in society. In order to ensure the sustainability and the harmonious relationship between the Group’s business and the environment, the Group recognises the importance of integrating Environmental, Social and Governance (“ESG”) aspects to enhance the Group’s daily operation and corporate governance perspective. The Governance Structure To demonstrate our commitment to sustainability, we have integrated corporate governance structure in preparing the Environmental, Social and Governance report (the “ESG Report”) of the Company. We have established a corporate governance framework to ensure that ESG governance aligns with our strategic growth. The governance structure of our Group consists of three components, namely the board (the “Board”) of directors (the “Directors”) of the Company, the ESG working group and the internal audit department.